Good questions. Clear answers.
How does Tirzepatide work?
Tirzepatide acts on GLP-1 and GIP receptors involved in appetite, fullness, and metabolic signaling. A licensed provider determines whether treatment is appropriate for you.
What dose will I receive?
New-to-GLP-1 plans can begin with the dose schedule shown on this page. Transfer patients can submit their current prescription label for review. Your provider determines the medication and dose, and increases are not automatic.
Will my price increase if my dose changes?
No. Your subscription price stays the same if your clinician determines that a dose increase is appropriate while the same eligible plan remains active. Plan changes or re-enrollment may change pricing.
When will I be charged?
Card checkout places a temporary authorization hold for the plan price. We capture the treatment-plan payment after physician approval. If the physician determines during the initial evaluation that you are not a candidate, the hold is released with no consultation charge. If you cancel or refuse to proceed after consultation work begins, a $75 consultation fee applies; nonresponse follows the final 24-hour notice process in the Terms of Service. Your bank controls when a released hold disappears.
Is compounded Tirzepatide FDA-approved?
No. Compounded medications are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing. Prescription and clinician approval are required.